Please provide your email address to receive an email when new articles are posted on . The myriad manifestations of herpes simplex keratitis can be difficult to diagnose without a high suspicion, but ...
Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...
In a recent study published in the Virology Journal, a group of researchers evaluated the antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
SAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...
- Excision’s proprietary gene editing technology holds unique, curative potential to address the leading cause of corneal blindness in the United States - Global incidence of HSV keratitis is ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback